Interim Trial Results Of Russia's COVID Vaccine 'Sputnik V' Score 92% Efficacy
According to the interim trials, Russian COVID-19 vaccine, Sputnik V, has shown a 92% efficacy against the coronavirus. The human adenovirus vaccine uses a weakened and genetically modified virus to build an immune response. However, the mid-stage trials, which are yet to be peer-reviewed, were conducted on a small population of 16,000 participants. In India, the vaccine is being tested by Dr Reddy's Laboratories in association with the… read-more
Tags: Russia, Covid-19 Vaccine, Sputnik-V, Coronavirus, India, Dr Reddy's, Human Trials
Courtesy: Indian Express
Human Trails Of Israel's COVID-19 Vaccine 'Brilife' To Begin Soon
Israel has announced it will begin human trails of its COVID-19 vaccine, named 'Brilife', by the end of the October. Reportedly, the vaccine was developed in August, and now will go through the regulatory processes. It is being developed by the Israel Institute of Biological Research (IIRB). However, it has not been communicated that by when the trials will be concluded or when the… read-more
Tags: Covid-19, Covid Vaccine, Human Trials, Israel
Courtesy: The Indian Express